Sutro Biopharma, a Bay Area oncology biotech company, is laying off around half its staff, switching up its leadership team ...

This makes them promising candidates for new anti-cancer drugs. Although a diverse range of bioactives exists, the development of new anti-cancer drugs is proving difficult, because of the time ...

During her doctoral program at UTEP, Villanueva conducted much of the research that led to the discovery of pyronaridine as ...

Successful treatment of severe lung cancer caused by third-generation EGFR-TKI resistance due to EGFR genotype conversion with afatinib plus anlotinib. Complete response of recurrent perihilar ...

MaineHealth Innovation is investing $100,000 from its Bonfire Funding Program in a company co-founded by a MaineHealth care ...

Such resistance can develop when surviving cancer cells develop one or more mechanisms to accelerate the removal of noxious substances, including anti-cancer drugs. One of the most common mechanisms ...

with the most common cases of counterfeit drugs being anti-cancer drugs and opioid mediations, the latter of which are used to treat pain in patients with cancer. Menon spoke with CURE about the issue ...

Unlike chemotherapy with its known toxicity towards normal body systems, Namodenoson provides protective effectsRamat Gan, Israel, March 03, ...

Although participants in the study had greater rates of nonadherence postintervention, those who reported nonadherence at ...

Researchers from Karl Landsteiner University of Health Sciences (KL Krems) have discovered that combining two existing drugs ...

Innovative technologies such as artificial intelligence (AI), machine learning, and quantum computing can accelerate the design and discovery of novel drugs ... can create anti-cancer molecules ...